Alliance for Cancer Gene Therapy Inc

Analysis

Alliance for Cancer Gene Therapy Inc is a registered charity in United States, based in Stamford, CT. It received its IRS tax-exemption ruling in July 2001, 25 years ago. Its declared purposes cover philanthropy, voluntarism and grantmaking foundations, which this site groups under grant-making and general purposes. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending April 2023, Alliance for Cancer Gene Therapy Inc reported income of $3.2m and spending of $2.5m, leaving 23% of income unspent that year. Across the 4 years on record, from April 2020 to April 2023, income grew from $2.3m to $3.2m (+40%), an average of +12% a year. The sharpest change came in the year to April 2022, when income rose by 92%. Over the whole period it spent 83% of the income it received.

Among 19,413 United States charities whose main cause is grant-making and general purposes and that reported income, Alliance for Cancer Gene Therapy Inc sits at the 90th percentile: it is larger than about 90% of them. Against every charity in United States with reported income it ranks in the 89th percentile, and in the 88th percentile within CT. Charities of a similar size with the same main cause include Glades Academy Inc ($3.2m), United Way of Pennsylvania ($3.2m) and Lordship Foundation Inc ($3.2m).

On its Form 990 for the period ending April 2023, revenue came from contributions and grants 68% and program service revenue 6.1% of the total. Compensation of current officers, directors and key employees was $268k (11% of expenses). Other salaries and wages came to $124k. At year end it held assets of $7.9m against liabilities of $1.7m, net assets of $6.3m. It reported 2 employees.